Laboratory testing for von Willebrand's disease: An assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey

Thrombosis and Haemostasis

Volumn 82, Issue 4, 1999, Pages 1276-1282

  Favaloro, Emmanuel J ^a,b   Smith, Julian ^a   Petinos, Penny ^a   Hertzberg, Mark ^a   Koutts, Jerry ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b Sydney West Area Health Service NSW Health   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; COLLAGEN; RISTOCETIN; VON WILLEBRAND FACTOR;

ARTICLE; ASIA; AUSTRALIA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ELECTROIMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; LABORATORY TEST; NEW ZEALAND; PRIORITY JOURNAL; QUALITY CONTROL; THROMBOCYTE AGGLUTINATION; VON WILLEBRAND DISEASE;

EID: 0032860887     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614375     Document Type: Article

References (19)

1. Sadler JE, Gralnick HR. Commentary: A new classification for von Willebrand Disease. Blood 1994; 84: 676-9.
2. Sadler JE. Review: Von Willebrand Factor. J Biol Chem 1991; 266: 22777-80.
3. Moroose R, Hoyer LW. von Willebrand factor and platelet function. Ann Rev Med 1986; 37: 157-63.
4. Giddings JC, Peake IR. The investigation of factor VIII deficiency. In: Thompson JM, ed. Blood Coagulation and Haemostasis. New York: Churchill Livingstone, 1985: pp 135-207.
5. Girma J-P, Meyer D, Verweij CL, et al. Structure-function relationship of human von Willebrand factor. Blood 1987; 70: 605-11.
6. Sadler JE. A revised classification of von Willebrand Disease. For the Subcommittee on von Willebrand Factor of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1994; 71: 520-5.
7. Guidelines for the diagnosis and management of von Willebrand Disease. Prepared by the Von Willebrand Working Party of the United Kingdom Haemophilia Centre Directors' Organisation. 1995.
8. Sadler JE, Foster PA, George JN. Haemostasis/Platelets. In: Haematology 1996. The Education Program of the American Society of Hematology. JR McArthur (ed); pp 79-94.
9. Favaloro EJ and Koutts J. Laboratory assays for von Willebrand Factor: Relative contribution to the diagnosis of von Willebrand's disease. Pathology 1997; 29: 385-391.
10. Brown RA, Rodgers GM. von Willebrand's Disease. Check Sample. Clinical Haematology No. CH 96-4 (CH-14). American Society of Clinical Pathologists 1996; pp 45-62.
11. Fleming TGM. von Willebrand factor: its function and its measurement in the laboratory. Br J Biomed Sci 1995; 52: 50-7.
12. Favaloro EJ, Grispo L, Dinale A, Berndt M, Koutts J. von Willebrand's Disease: Laboratory investigation using an improved functional assay for von Willebrand factor. Pathology 1993; 25: 152-8.
13. Favaloro EJ, Facey D, Grispo L. Laboratory assessment of von Willebrand factor: Use of different assays can influence the diagnosis of von Willebrand's disease, dependent on differing sensitivity to sample preparation and differential recognition of high molecular weight VWF forms. Am J Clin Pathol 1995; 104: 264-71.
14. Goodall AH, Jarvis J, Chand S, Rawlings E, O'Brien DP, McCraw A, Hutton R, Tuddenham EGD. An immunoradiometric assay for human factor VIII von Willebrand factor (VIII:VWF) using a monoclonal antibody based that defines a functional epitope. Br J Haem 1985; 59: 565-77.
15. Chand S, McCraw A, Hutton R, Tuddenham EGD, Goodall AH. A two-site, monoclonal antibody based immunoassay for von Willebrand factor -Demonstration that VWF function resides in a conformational epitope. Thromb Haemost 1986; 55: 318-24.
16. Murdock PJ, Woodhams BJ, Mathews KB, Pasi KJ, Goodall AH. von Willebrand factor activity detected in a monoclonal antibody-based ELISA: an alternative to the Ristocetin cofactor platelet agglutination assay for diagnostic use. Thromb Haemost 1997; 78: 1272-7.
17. Fischer BE, Thomas KB, Dorner F. von Willebrand factor: measuring its antigen of function? Correlation between the level of antigen, activity, and multimer size using various detection systems. Thromb Res 1998; 91: 39-43.
18. Casonato A, Pontara E, Bertomoro A, Zucchetto S, Zerbinati P, Girlami A. Abnormal collagen binding activity of 2A von Willebrand factor: evidence that the defect depends only on the lack of large multimers. J Lab Clin Med 1997; 129: 251-9.
19. Preston FE. Assays for von Willebrand Factor Functional Activity: A UK NEQAS Survey. Thromb Haemost 1998; 80: 863.